|
2025
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention an... |
|
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, A... |
|
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of obstructive... |
|
|
G/S
|
Product development; Pharmaceutical products development; Biological development services; Resear... |
|
|
G/S
|
Medical and scientific research in the field of solid tumors |
|
|
G/S
|
Venture capital financing; venture capital services, namely, providing financing to seed and earl... |
|
|
G/S
|
Scientific laboratory services, namely, providing shared wet laboratory facilities and shared lab... |
|
|
G/S
|
Pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail s... |
|
2024
|
G/S
|
Medical and scientific research in the field of solid tumors. |
|
|
G/S
|
Patient services programs and related programs and activities relating to Alzheimer patients and ... |
|
|
G/S
|
Medical information services in the field of atopic dermatitis. |
|
|
G/S
|
Medical information services |
|
|
G/S
|
Medical information services in the field of atopic dermatitis |
|
|
G/S
|
Medical and scientific research in the field of cardiovascular diseases and disorders |
|
|
Invention
|
Methods of treating ulcerative colitis.
The present invention generally relates to the treatment... |
|
|
G/S
|
Medical information services in the field of inflammatory bowel disease and autoimmune diseases a... |
|
|
G/S
|
Educational services, namely, programs for healthcare personnel about clinical cases and communic... |
|
|
G/S
|
Medical information services, namely providing information related to Alzheimer's disease |
|
|
G/S
|
Custom manufacturing of pharmaceuticals and clinical trial materials Pharmaceutical products deve... |
|
|
Invention
|
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-pipe... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of obesity |
|
|
G/S
|
Medical information services, namely providing information related to diabetes |
|
|
G/S
|
A tool used for assessing diabetes treatment, namely, printed questionnaires |
|
|
Invention
|
Long-acting amylin receptor agonists and uses thereof.
The present disclosure relates to the fie... |
|
|
G/S
|
Battery Chargers |
|
|
Invention
|
Process to make glp1 ra and intermediates therefor.
The present invention relates to the synthes... |
|
|
Invention
|
Engineered antibody compounds and conjugates thereof.
Engineered antibody compounds and conjugat... |
|
|
Invention
|
Processes and intermediates for preparing tirzepatide.
The present invention provides new interm... |
|
|
Invention
|
Three resin reactors in series peptide synthesizer.
A Solid Phase Peptide Synthesis (SPPS) devic... |
|
|
Invention
|
Process for preparing a gip/glp1 dual agonist.
The present invention provides novel intermediate... |
|
|
Invention
|
Solid forms of a kv1.3 potassium shaker channel blockers and method of using the same. Solid form... |
|
|
Invention
|
Piperidine, morpholine and tetrahydro-pyridazine compounds with lp(a) lowering activity. The pres... |
|
|
Invention
|
Piperidine compounds with lp(a) lowering activity. The present disclosure provides compounds of t... |
|
|
Invention
|
Root cause analysis for machines in manufacturing network. A method for managing a manufacturing ... |
|
|
Invention
|
Pyrrolidine compounds lp(a) lowering activity. The present disclosure provides compounds of the f... |
|
|
Invention
|
Pyrrolidine compounds with lp(a) lowering activity. The present disclosure provides compounds of ... |
|
|
Invention
|
Fusion proteins.
The present invention relates to fusion proteins comprising an insulin receptor... |
|
|
Invention
|
Therapeutic uses and doses of lp(a) disrupter compounds. Once-daily, oral doses of the Lp(a) disr... |
|
|
Invention
|
Methods and systems for predicting changes in physiological parameters of a patient. The present ... |
|
|
Invention
|
Nectin-4 antibodies and antibody-drug conjugates. The present disclosure provides nectin-4 antibo... |
|
|
Invention
|
Needle assembly and fluid delivery system with needle assembly. One or more needle assemblies for... |
|
|
Invention
|
Compounds for the delivery of granulin across the blood brain barrier. Compounds for the delivery... |
|
|
Invention
|
Dosage regimens for the treatment of autoimmune and inflammatory diseases using ly3871801. Disclo... |
|
|
Invention
|
Optical sensing techniques for dose delivery. A medication delivery device is provided having a d... |
|
|
Invention
|
Methods and systems for detecting defects using topological persistence features. The techniques ... |
|
|
Invention
|
Pan-elr+ cxc chemokine antibodies for the treatment of hidradenitis suppurativa.
Provided herein... |
|
|
Invention
|
Medication delivery systems and methods including injection site determination and tracking. A me... |
|
|
Invention
|
Antibodies targeting xcl1 and methods of using the same.
The present invention provides compound... |
|
|
Invention
|
Antibodies targeting xcl1 and methods of using the same. The present invention provides compounds... |
|
|
Invention
|
Novel scn10a rnai agents and uses thereof. The present invention relates to therapeutic compounds... |
|
|
Invention
|
Treatment or prevention of new-onset type 1 diabetes with baricitinib.
The present invention pro... |
|
|
Invention
|
Medication delivery device connection techniques. A method is provided for presenting information... |
|
|
Invention
|
Oligonucleotide synthesis using cyclic-phosphorous nucleosides. The present disclosure provides m... |
|
|
Invention
|
Imlunestrant or salts thereof for use in treating and preventing central nervous system (cns) met... |
|
|
Invention
|
Kras inhibitors.
The present invention provides compounds of the formula:
The present inventio... |
|
2023
|
Invention
|
Treatment or prevention of new-onset type 1 diabetes with baricitinib. The present invention prov... |
|
|
Invention
|
Methods and systems for selecting an injection site. Methods and systems are provided for evaluat... |
|
2022
|
Invention
|
Cdk4 and 6 inhibitor in combination with fulvestrant for the treatment of hormone receptor-positi... |
|
|
Invention
|
Systems and methods for identifying subjects for clinical trials.
A computing device is provided... |
|
|
Invention
|
Preserved formulations.
Described herein are preserved formulations of insulin-Fc fusions. The f... |
|
|
Invention
|
Display screen with an icon |
|
|
Invention
|
Stabilizer for medication delivery device.
The present disclosure relates to a medication delive... |
|
|
Invention
|
Anti-il-23p19 antibody regulation of genes involved in bowel urgency in ulcerative colitis.
The ... |
|
|
Invention
|
Anti-il-1-beta antibodies.
The present invention provides engineered human interleukin-1 beta an... |
|
|
Invention
|
Systems and methods for sensing defecation events.
Systems and methods facilitate sensing and ta... |
|
|
Invention
|
Therapeutic agent delivery device including disposable and reusable portions.
A therapeutic agen... |
|
|
Invention
|
Treatment of hand eczema with baricitinib.
Methods of treating Hand Eczema with baricitinib, inc... |
|
2021
|
Invention
|
Rna therapeutics and methods of use thereof.
ADAR activating RNA, RNA therapeutics comprising an... |
|
2020
|
Invention
|
Drug delivery device |
